1. Home
  2. SVRA vs MEG Comparison

SVRA vs MEG Comparison

Compare SVRA & MEG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SVRA
  • MEG
  • Stock Information
  • Founded
  • SVRA 2007
  • MEG 2012
  • Country
  • SVRA United States
  • MEG United States
  • Employees
  • SVRA N/A
  • MEG N/A
  • Industry
  • SVRA Biotechnology: Pharmaceutical Preparations
  • MEG Professional Services
  • Sector
  • SVRA Health Care
  • MEG Consumer Discretionary
  • Exchange
  • SVRA Nasdaq
  • MEG Nasdaq
  • Market Cap
  • SVRA 528.3M
  • MEG 488.4M
  • IPO Year
  • SVRA N/A
  • MEG 2020
  • Fundamental
  • Price
  • SVRA $2.06
  • MEG $21.77
  • Analyst Decision
  • SVRA Buy
  • MEG Buy
  • Analyst Count
  • SVRA 7
  • MEG 5
  • Target Price
  • SVRA $7.57
  • MEG $31.80
  • AVG Volume (30 Days)
  • SVRA 2.5M
  • MEG 371.5K
  • Earning Date
  • SVRA 08-11-2025
  • MEG 08-05-2025
  • Dividend Yield
  • SVRA N/A
  • MEG N/A
  • EPS Growth
  • SVRA N/A
  • MEG N/A
  • EPS
  • SVRA N/A
  • MEG N/A
  • Revenue
  • SVRA N/A
  • MEG $718,904,000.00
  • Revenue This Year
  • SVRA N/A
  • MEG $10.49
  • Revenue Next Year
  • SVRA N/A
  • MEG $7.06
  • P/E Ratio
  • SVRA N/A
  • MEG N/A
  • Revenue Growth
  • SVRA N/A
  • MEG 10.92
  • 52 Week Low
  • SVRA $1.89
  • MEG $10.51
  • 52 Week High
  • SVRA $5.11
  • MEG $49.66
  • Technical
  • Relative Strength Index (RSI)
  • SVRA 34.43
  • MEG 57.00
  • Support Level
  • SVRA $2.13
  • MEG $21.96
  • Resistance Level
  • SVRA $2.49
  • MEG $24.00
  • Average True Range (ATR)
  • SVRA 0.15
  • MEG 1.01
  • MACD
  • SVRA -0.01
  • MEG -0.10
  • Stochastic Oscillator
  • SVRA 8.41
  • MEG 51.73

About SVRA Savara Inc.

Savara Inc is a biopharmaceutical company. It is focused on rare respiratory diseases. The company's program, molgramostim nebulizer solution (molgramostim), is an inhaled granulocyte-macrophage colony-stimulating factor in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP). It has one segment specialty pharmaceuticals within the respiratory system.

About MEG Montrose Environmental Group Inc.

Montrose Environmental Group Inc is an environmental services company. The firm's operating segments are Assessment, Permitting and Response, Measurement and Analysis, and Remediation and Reuse. Through its Assessment, Permitting, and Response segment, the company provides scientific advisory and consulting services to support environmental assessments, environmental emergency response, and environmental audits. Measurement and Analysis include test and analysis of air, water, and soil to determine concentrations of contaminants whereas, the Remediation and Reuse segment provide clients with engineering, design, implementation, operations and maintenance services, to treat contaminated water, remove contaminant or create biogas. United States Contributes the majority of geographic revenue.

Share on Social Networks: